Publication | Open Access

Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate

Weekly TrastuzumabHer2 StatusBreast OncologyMedicinePathologyBreast CancerResponse RateCancer TreatmentOncologyRadiation OncologyEndocrine-related Cancer